CFL1 expression levels as a prognostic and drug resistance marker in nonsmall cell lung cancer-Reference-Cited by-同舟云学术

CFL1 expression levels as a prognostic and drug resistance marker in nonsmall cell lung cancer

Published:2010-04-29 Issue:15 Volume:116 Page:3645-3655
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Castro Mauro Antonio Alves,Dal-Pizzol Felipe,Zdanov Stephanie,Soares Marcio,Müller Carolina Beatriz,Lopes Fernanda Martins,Zanotto-Filho Alfeu,Fernandes Marilda da Cruz,Moreira Jose Claudio Fonseca,Shacter Emily,Klamt Fábio

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference37 articles.

1. Cancer Statistics, 2009;Jemal;CA Cancer J Clin,2009

2. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer;Potti;N Engl J Med,2006

3. AJCC Cancer Staging Manual

4. Biomarkers in cancer staging, prognosis and treatment selection;Ludwig;Nat Rev Cancer,2005

5. Gene expression patterns, prognostic and diagnostic markers, and lung cancer biology;Kaminski;Chest,2004

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A glimpse into cofilin-1 role in cancer therapy: A potential target to improve clinical outcomes?;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03

2. PLEK2 mediates metastasis and invasion via α5‐nAChR activation in nicotine‐induced lung adenocarcinoma;Molecular Carcinogenesis;2023-11-03

3. Docetaxel Resistance in Castration-Resistant Prostate Cancer: Transcriptomic Determinants and the Effect of Inhibiting Wnt/β-Catenin Signaling by XAV939;International Journal of Molecular Sciences;2022-10-25

4. Critical pathways of oral squamous cell carcinoma: molecular biomarker and therapeutic intervention;Medical Oncology;2022-01-20

5. Effects and mechanisms of FBXO31 on Taxol chemoresistance in esophageal squamous cell carcinoma;Biochemical and Biophysical Research Communications;2022-01